{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:51:14Z","timestamp":1781740274024,"version":"3.54.5"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"DOI":"10.1186\/s13023-026-04362-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:05:21Z","timestamp":1777025121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of health-related quality of life in adults with cystic fibrosis: the role of selected sociodemographic and treatment-related factors"],"prefix":"10.1186","volume":"21","author":[{"given":"Dorota","family":"Snop-Perkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4832-8094","authenticated-orcid":false,"given":"Jakub","family":"\u015awitalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Krzych-Fa\u0142ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Augustynowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"1","key":"4362_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/uro1010003","volume":"1","author":"T Cai","year":"2021","unstructured":"Cai T, Verze P, Bjerklund Johansen TE. The Quality of Life Definition. Where Are We Going? Uro. 2021;1(1):14\u201322. https:\/\/doi.org\/10.3390\/uro1010003.","journal-title":"Where Are We Going? Uro"},{"issue":"6","key":"4362_CR2","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s11136-024-03632-0","volume":"33","author":"H Jia","year":"2024","unstructured":"Jia H, Lubetkin EI. Relative importance of selected predictors of health-related quality-of-life (HRQOL) among U.S. adults. Qual Life Res. 2024;33(6):1633\u201345. https:\/\/doi.org\/10.1007\/s11136-024-03632-0.","journal-title":"Qual Life Res"},{"issue":"1","key":"4362_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12955-020-01347-7","volume":"18","author":"NPF Pequeno","year":"2020","unstructured":"Pequeno NPF, Cabral NLA, Marchioni DM, Lima SCVC, Lyra CO. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. 2020;18(1):208. https:\/\/doi.org\/10.1186\/s12955-020-01347-7.","journal-title":"Health Qual Life Outcomes"},{"key":"4362_CR4","doi-asserted-by":"publisher","first-page":"1313685","DOI":"10.3389\/fpubh.2024.1313685","volume":"12","author":"F Riecke","year":"2024","unstructured":"Riecke F, Bauer L, Polzer H, Baumbach SF, Neuerburg C, B\u00f6cker W, et al. Effects of medical interventions on health-related quality of life in chronic disease - systematic review and meta-analysis of the 19 most common diagnoses. Front Public Health. 2024;12:1313685. https:\/\/doi.org\/10.3389\/fpubh.2024.1313685.","journal-title":"Front Public Health"},{"issue":"10","key":"4362_CR5","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","volume":"28","author":"K Haraldstad","year":"2019","unstructured":"Haraldstad K, Wahl A, Anden\u00e6s R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641\u201350. https:\/\/doi.org\/10.1007\/s11136-019-02214-9.","journal-title":"Qual Life Res"},{"issue":"1","key":"4362_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65\u2013124. https:\/\/doi.org\/10.1016\/S2213-2600(19)30337-6.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4362_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","volume":"14","author":"L Allen","year":"2023","unstructured":"Allen L, Allen L, Carr SB, Davies G, Downey D, Egan M, et al. Future therapies for cystic fibrosis. Nat Commun. 2023;14(1):693. https:\/\/doi.org\/10.1038\/s41467-023-36244-2.","journal-title":"Nat Commun"},{"issue":"1","key":"4362_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","volume":"10","author":"MA Mall","year":"2024","unstructured":"Mall MA, Burgel PR, Castellani C, Davies JC, Salathe M, Taylor-Cousar JL. Cystic fibrosis. Nat Rev Dis Primers. 2024;10(1):53. https:\/\/doi.org\/10.1038\/s41572-024-00538-6.","journal-title":"Nat Rev Dis Primers"},{"issue":"173","key":"4362_CR9","doi-asserted-by":"publisher","first-page":"240045","DOI":"10.1183\/16000617.0045-2024","volume":"33","author":"I Fajac","year":"2024","unstructured":"Fajac I, Burgel PR, Martin C. New drugs, new challenges in cystic fibrosis care. Eur Respir Rev. 2024;33(173):240045. https:\/\/doi.org\/10.1183\/16000617.0045-2024.","journal-title":"Eur Respir Rev"},{"issue":"6","key":"4362_CR10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/ppul.26954","volume":"59","author":"J Guo","year":"2024","unstructured":"Guo J, King I, Hill A. International disparities in diagnosis and treatment access for cystic fibrosis. Pediatr Pulmonol. 2024;59(6):1622\u201330. https:\/\/doi.org\/10.1002\/ppul.26954.","journal-title":"Pediatr Pulmonol"},{"key":"4362_CR11","unstructured":"European Cystic Fibrosis Society Patient Registry. 2023 Annual Data Report. 2025. https:\/\/pr.ecfs.eu\/annual-reports\/. Accessed 8 Mar 2026."},{"key":"4362_CR12","unstructured":"e-Health Centre. Number of patients diagnosed with cystic fibrosis. 2024. https:\/\/ezdrowie.gov.pl\/18956. Accessed 8 Mar 2026."},{"issue":"2","key":"4362_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MCP.0000000000000244","volume":"22","author":"AL Quittner","year":"2016","unstructured":"Quittner AL, Saez-Flores E, Barton JD. The psychological burden of cystic fibrosis. Curr Opin Pulm Med. 2016;22(2):187\u201391. https:\/\/doi.org\/10.1097\/MCP.0000000000000244.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"4362_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ccm.2022.06.014","volume":"43","author":"CJ Bathgate","year":"2022","unstructured":"Bathgate CJ, Hjelm M, Filigno SS, Smith BA, Georgiopoulos AM. Management of Mental Health in Cystic Fibrosis. Clin Chest Med. 2022;43(4):791\u2013810. https:\/\/doi.org\/10.1016\/j.ccm.2022.06.014.","journal-title":"Clin Chest Med"},{"issue":"2","key":"4362_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jcf.2021.08.011","volume":"21","author":"V Leso","year":"2022","unstructured":"Leso V, Romano R, Santocono C, Caruso M, Iacotucci P, Carnovale V, et al. The impact of cystic fibrosis on the working life of patients: A systematic review. J Cyst Fibros. 2022;21(2):361\u20139. https:\/\/doi.org\/10.1016\/j.jcf.2021.08.011.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"4362_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jcf.2024.11.012","volume":"24","author":"EP Dellon","year":"2025","unstructured":"Dellon EP, Allada G, Allgood SJ, Georgiopoulos AM, Goggin JL, Hadjiliadis D, et al. Addressing pain in people living with cystic fibrosis: Cystic fibrosis foundation evidence-informed guidelines. J Cyst Fibros. 2025;24(2):224\u201335. https:\/\/doi.org\/10.1016\/j.jcf.2024.11.012.","journal-title":"J Cyst Fibros"},{"issue":"9","key":"4362_CR17","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s11136-025-03976-1","volume":"34","author":"T Kangas","year":"2025","unstructured":"Kangas T, Milis SL, Vanthomme K, Vandenheede H. The social determinants of health-related quality of life among people with chronic disease: a systematic literature review. Qual Life Res. 2025;34(9):2501\u201311. https:\/\/doi.org\/10.1007\/s11136-025-03976-1.","journal-title":"Qual Life Res"},{"issue":"1","key":"4362_CR18","doi-asserted-by":"publisher","first-page":"e1004154","DOI":"10.1371\/journal.pmed.1004154","volume":"20","author":"EW Butterly","year":"2023","unstructured":"Butterly EW, Hanlon P, Shah ASV, Hannigan LJ, McIntosh E, Lewsey J, et al. Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis. PLoS Med. 2023;20(1):e1004154. https:\/\/doi.org\/10.1371\/journal.pmed.1004154.","journal-title":"PLoS Med"},{"issue":"1","key":"4362_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12955-024-02312-4","volume":"22","author":"JM Bonsel","year":"2024","unstructured":"Bonsel JM, Itiola AJ, Huberts AS, Bonsel GJ, Penton H. The use of patient-reported outcome measures to improve patient-related outcomes - a systematic review. Health Qual Life Outcomes. 2024;22(1):101. https:\/\/doi.org\/10.1186\/s12955-024-02312-4.","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"4362_CR20","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jval.2024.05.013","volume":"27","author":"L Wittich","year":"2024","unstructured":"Wittich L, Tsatsaronis C, Kuklinski D, Sch\u00f6ner L, Steinbeck V, Busse R, et al. Patient-Reported Outcome Measures as an Intervention: A Comprehensive Overview of Systematic Reviews on the Effects of Feedback. Value Health. 2024;27(10):1436\u201353. https:\/\/doi.org\/10.1016\/j.jval.2024.05.013.","journal-title":"Value Health"},{"issue":"2","key":"4362_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0031-3939(09)70151-9","volume":"84","author":"D Sands","year":"2009","unstructured":"Sands D, Borawska-Kowalczyk U. Validation of Polish version of \u2013 Specific Quality of Life Questionnaire for Cystic Fibrosis (CFQ-R). Pediatria Polska. 2009;84(2):165\u201372. https:\/\/doi.org\/10.1016\/S0031-3939(09)70151-9.","journal-title":"Pediatria Polska"},{"key":"4362_CR22","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.2147\/PPA.S88385","volume":"9","author":"G D\u0119bska","year":"2015","unstructured":"D\u0119bska G, Mazurek H. Factors related to changes in the quality of life among Polish adolescents and adults with cystic fibrosis over a 1-year period. Patient Prefer Adherence. 2015;9:1763\u201370. https:\/\/doi.org\/10.2147\/PPA.S88385.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"4362_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.17219\/acem\/38147","volume":"24","author":"I Uchmanowicz","year":"2015","unstructured":"Uchmanowicz I, Jankowska-Pola\u0144ska B, Rosi\u0144czuk J, Wleklik M. Health-related quality of life of patients suffering from cystic fibrosis. Adv Clin Exp Med. 2015;24(1):147\u201352. https:\/\/doi.org\/10.17219\/acem\/38147.","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"4362_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.hrtlng.2018.08.003","volume":"48","author":"L Tomaszek","year":"2019","unstructured":"Tomaszek L, D\u0119bska G, Cepuch G, Kulpa M, Pawlik L, Broniatowska E. Evaluation of quality of life predictors in adolescents and young adults with cystic fibrosis. Heart Lung. 2019;48(2):159\u201365. https:\/\/doi.org\/10.1016\/j.hrtlng.2018.08.003.","journal-title":"Heart Lung"},{"issue":"1","key":"4362_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5114\/ppiel.2023.129136","volume":"31","author":"A Siczek","year":"2023","unstructured":"Siczek A, Kobos E. Life quality of adult patients with cystic fibrosis. Nurs Probl. 2023;31(1):29\u201336. https:\/\/doi.org\/10.5114\/ppiel.2023.129136.","journal-title":"Nurs Probl"},{"issue":"12","key":"4362_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3390\/healthcare12121183","volume":"12","author":"M Humaj-Grysztar","year":"2024","unstructured":"Humaj-Grysztar M, Rachel M, Bonior J. Polish Cystic Fibrosis Patients\u2019 Health-Related Quality of Life and Its Influencing Factors: A Cross-Sectional, Single-Centre Study. Healthc (Basel). 2024;12(12):1183. https:\/\/doi.org\/10.3390\/healthcare12121183.","journal-title":"Healthc (Basel)"},{"issue":"1","key":"4362_CR27","doi-asserted-by":"publisher","first-page":"9264","DOI":"10.1038\/s41598-025-94184-x","volume":"15","author":"D Snop-Perkowska","year":"2025","unstructured":"Snop-Perkowska D, \u015awitalski J, Fedorowski JJ, Augustynowicz A. Measurement properties of the Polish version of the Cystic Fibrosis Questionnaire Revised 14\u2009+\u2009in the adult population. Sci Rep. 2025;15(1):9264. https:\/\/doi.org\/10.1038\/s41598-025-94184-x.","journal-title":"Sci Rep"},{"key":"4362_CR28","doi-asserted-by":"publisher","first-page":"112444","DOI":"10.1016\/j.jpsychores.2025.112444","volume":"199","author":"D Snop-Perkowska","year":"2025","unstructured":"Snop-Perkowska D, \u015awitalski J, Wi\u015bniewska E, Olszewski P, Augustynowicz A. Assessment of anxiety and depression symptoms severity among polish adult patients with cystic fibrosis: impact of selected sociodemographic and health variables. J Psychosom Res. 2025;199:112444. https:\/\/doi.org\/10.1016\/j.jpsychores.2025.112444.","journal-title":"J Psychosom Res"},{"issue":"3","key":"4362_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1187\/cbe.13-04-0082","volume":"12","author":"JM Maher","year":"2013","unstructured":"Maher JM, Markey JC, Ebert-May D. The other half of the story: effect size analysis in quantitative research. CBE Life Sci Educ. 2013;12(3):345\u201351. https:\/\/doi.org\/10.1187\/cbe.13-04-0082.","journal-title":"CBE Life Sci Educ"},{"issue":"3","key":"4362_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tjem.2018.08.001","volume":"18","author":"H Akoglu","year":"2018","unstructured":"Akoglu H. User\u2019s guide to correlation coefficients. Turk J Emerg Med. 2018;18(3):91\u20133. https:\/\/doi.org\/10.1016\/j.tjem.2018.08.001.","journal-title":"Turk J Emerg Med"},{"key":"4362_CR31","doi-asserted-by":"publisher","DOI":"10.4324\/9781032622156","volume-title":"IBM SPSS statistics 29 step by step: A simple guide and reference","author":"D George","year":"2024","unstructured":"George D, Mallery P. IBM SPSS statistics 29 step by step: A simple guide and reference. New York, London: Routledge; 2024."},{"issue":"1","key":"4362_CR32","doi-asserted-by":"publisher","first-page":"e002606","DOI":"10.1136\/bmjresp-2024-002606","volume":"12","author":"M Harrigan","year":"2025","unstructured":"Harrigan M, Georgiopoulos AM, Quittner AL, Smith B, Douglas TA. Psychosocial and mental health in cystic fibrosis in the modern era of care: time to evolve. BMJ Open Respir Res. 2025;12(1):e002606. https:\/\/doi.org\/10.1136\/bmjresp-2024-002606.","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"4362_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/healthcare14030351","volume":"14","author":"MI Griff","year":"2026","unstructured":"Griff MI, Santos R, Trumello C, Brand\u00e3o T. Psychosocial Aspects of Cystic Fibrosis: A Mixed-Methods Systematic Review. Healthc (Basel). 2026;14(3):351. https:\/\/doi.org\/10.3390\/healthcare14030351.","journal-title":"Healthc (Basel)"},{"key":"4362_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.prrv.2024.08.001","volume":"54","author":"R Dobra","year":"2025","unstructured":"Dobra R, Carroll S, Davies JC, Dowdall F, Duff A, Elderton A, et al. Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges. Paediatr Respir Rev. 2025;54:35\u201342. https:\/\/doi.org\/10.1016\/j.prrv.2024.08.001.","journal-title":"Paediatr Respir Rev"},{"key":"4362_CR35","doi-asserted-by":"publisher","first-page":"101085","DOI":"10.1016\/j.vhri.2025.101085","volume":"47","author":"T Mlcoch","year":"2025","unstructured":"Mlcoch T, Decker B, Tuzil J, Turkova B, Doleckova K, Koznarova B, et al. Life With Cystic Fibrosis: The Socioeconomic Impact on Patients and Their Caregivers. Value Health Reg Issues. 2025;47:101085. https:\/\/doi.org\/10.1016\/j.vhri.2025.101085.","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"4362_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4187\/respcare.06356","volume":"64","author":"JA Cronly","year":"2019","unstructured":"Cronly JA, Duff AJ, Riekert KA, Fitzgerald AP, Perry IJ, Lehane EA, et al. Health-Related Quality of Life in Adolescents and Adults With Cystic Fibrosis: Physical and Mental Health Predictors. Respir Care. 2019;64(4):406\u201315. https:\/\/doi.org\/10.4187\/respcare.06356.","journal-title":"Respir Care"},{"issue":"10","key":"4362_CR37","doi-asserted-by":"publisher","first-page":"e71306","DOI":"10.1002\/ppul.71306","volume":"60","author":"S DiFiglia","year":"2025","unstructured":"DiFiglia S, Georgiopoulos AM, Seng EK, Portenoy R, Chaudhary N, Yonker LM, et al. Illness Burden in Adults With Cystic Fibrosis: Associations With Sex, Race\/Ethnicity, and Socioeconomic Risk Factors. Pediatr Pulmonol. 2025;60(10):e71306. https:\/\/doi.org\/10.1002\/ppul.71306.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"4362_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jval.2022.12.002","volume":"26","author":"S Acaster","year":"2023","unstructured":"Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, et al. Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised. Value Health. 2023;26(4):567\u201378. https:\/\/doi.org\/10.1016\/j.jval.2022.12.002.","journal-title":"Value Health"},{"key":"4362_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1824-7288-40-50","volume":"40","author":"R Bodnar","year":"2014","unstructured":"Bodnar R, Kadar L, Holics K, Ujhelyi R, Kovacs L, Bolbas K, et al. Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis. Ital J Pediatr. 2014;40:50. https:\/\/doi.org\/10.1186\/1824-7288-40-50.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"4362_CR40","doi-asserted-by":"publisher","first-page":"e14564","DOI":"10.1111\/sms.14564","volume":"34","author":"A Sosa-Pedreschi","year":"2024","unstructured":"Sosa-Pedreschi A, Donadio MVF, Iturriaga-Ram\u00edrez T, Yvert T, P\u00e9rez-Salazar F, Santiago-Dorrego C, et al. Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: Randomized controlled trial. Scand J Med Sci Sports. 2024;34(1):e14564. https:\/\/doi.org\/10.1111\/sms.14564.","journal-title":"Scand J Med Sci Sports"},{"issue":"23","key":"4362_CR41","doi-asserted-by":"publisher","first-page":"16056","DOI":"10.3390\/ijerph192316056","volume":"19","author":"M Humaj-Grysztar","year":"2022","unstructured":"Humaj-Grysztar M, Rachel M, \u015amiech-Michalec O, Bonior J. Mental Health of Cystic Fibrosis Patients and the COVID-19 Pandemic in Poland: A Single-Center Comparative Study. Int J Environ Res Public Health. 2022;19(23):16056. https:\/\/doi.org\/10.3390\/ijerph192316056.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"4362_CR42","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/healthcare10071351","volume":"10","author":"J Ancel","year":"2022","unstructured":"Ancel J, Launois C, Perotin JM, Ravoninjatovo B, Mulette P, Hagenburg J, et al. Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthc (Basel). 2022;10(7):1351. https:\/\/doi.org\/10.3390\/healthcare10071351.","journal-title":"Healthc (Basel)"},{"issue":"17","key":"4362_CR43","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.3390\/healthcare13172194","volume":"13","author":"W Gruber","year":"2025","unstructured":"Gruber W, Stehling F, Schermaul JS, Ortiz JG, Lechtenberg L, Taube C, et al. Predictors of Physical Activity Enjoyment in Adults with Cystic Fibrosis: The Role of Quality of Life and Motivation-A Single-Center Study. Healthc (Basel). 2025;13(17):2194. https:\/\/doi.org\/10.3390\/healthcare13172194.","journal-title":"Healthc (Basel)"},{"key":"4362_CR44","doi-asserted-by":"publisher","unstructured":"Ribeiro Mo\u00e7o VJ, Lopes AJ, Vig\u00e1rio Pdos S, de Almeida VP, de Menezes SL, Guimar\u00e3es FS. Pulmonary function, functional capacity and quality of life in adults with cystic fibrosis. Rev Port Pneumol. 2006. 2015;21(4):198\u2013202. https:\/\/doi.org\/10.1016\/j.rppnen.2014.10.003.","DOI":"10.1016\/j.rppnen.2014.10.003"},{"issue":"1","key":"4362_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","volume":"71","author":"AL Quittner","year":"2016","unstructured":"Quittner AL, Abbott J, Georgiopoulos AM, Goldbeck L, Smith B, Hempstead SE, et al. International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71(1):26\u201334. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207488.","journal-title":"Thorax"},{"issue":"1","key":"4362_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3138\/ptc.2016-75","volume":"70","author":"C Orava","year":"2018","unstructured":"Orava C, Fitzgerald J, Figliomeni S, Lam D, Naccarato A, Szego E, et al. Relationship between Physical Activity and Fatigue in Adults with Cystic Fibrosis. Physiother Can. 2018;70(1):42\u20138. https:\/\/doi.org\/10.3138\/ptc.2016-75.","journal-title":"Physiother Can"},{"key":"4362_CR47","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.6061\/clinics\/2017\/e427","volume":"73","author":"DW Gancz","year":"2018","unstructured":"Gancz DW, Cunha MT, Leone C, Rodrigues JC, Adde FV. Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes. Clin (Sao Paulo). 2018;73:e427. https:\/\/doi.org\/10.6061\/clinics\/2017\/e427.","journal-title":"Clin (Sao Paulo)"},{"issue":"4","key":"4362_CR48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jcf.2025.03.004","volume":"24","author":"J Gravelle","year":"2025","unstructured":"Gravelle J, Desai S, Dong K, Quon BS. Vitality is associated with systemic inflammation in cystic fibrosis adults on elexacaftor\/tezacaftor\/ivacaftor. J Cyst Fibros. 2025;24(4):816\u20138. https:\/\/doi.org\/10.1016\/j.jcf.2025.03.004.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"4362_CR49","doi-asserted-by":"publisher","first-page":"1000375","DOI":"10.4172\/2161-105X.1000375","volume":"6","author":"E Matouk","year":"2016","unstructured":"Matouk E, Nguyen D, Benedetti A, Bernier J, Gruber J, Landry J, et al. C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations. J Pulm Respir Med. 2016;6(5):1000375. https:\/\/doi.org\/10.4172\/2161-105X.1000375.","journal-title":"J Pulm Respir Med"},{"key":"4362_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3310\/nihropenres.13260.1","volume":"2","author":"R Altabee","year":"2022","unstructured":"Altabee R, Carr SB, Abbott J, Cameron R, Office D, Matthews J, et al. Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis. NIHR Open Res. 2022;2:36. https:\/\/doi.org\/10.3310\/nihropenres.13260.1.","journal-title":"NIHR Open Res"},{"issue":"3","key":"4362_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jcf.2024.11.005","volume":"24","author":"R Altabee","year":"2025","unstructured":"Altabee R, Mwamba MJ, Turner D, Davies G, Abbott J, Simmonds NJ, et al. Measurement of treatment burden in cystic fibrosis: A systematic review. J Cyst Fibros. 2025;24(3):434\u201345. https:\/\/doi.org\/10.1016\/j.jcf.2024.11.005.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"4362_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.chest.2022.07.008","volume":"162","author":"RA Cameron","year":"2022","unstructured":"Cameron RA, Office D, Matthews J, Rowley M, Abbott J, Simmonds NJ, et al. Treatment Preference Among People With Cystic Fibrosis: The Importance of Reducing Treatment Burden. Chest. 2022;162(6):1241\u201354. https:\/\/doi.org\/10.1016\/j.chest.2022.07.008.","journal-title":"Chest"},{"issue":"1","key":"4362_CR53","doi-asserted-by":"publisher","first-page":"00475","DOI":"10.1183\/23120541.00475-2020","volume":"7","author":"GY Lam","year":"2021","unstructured":"Lam GY, Goodwin J, Wilcox PG, Quon BS. Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes. ERJ Open Res. 2021;7(1):00475\u20132020. https:\/\/doi.org\/10.1183\/23120541.00475-2020.","journal-title":"ERJ Open Res"},{"issue":"6","key":"4362_CR54","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/jpm13060924","volume":"13","author":"C G\u00e4rtner","year":"2023","unstructured":"G\u00e4rtner C, Fallmann J, Stadler PF, Kaiser T, Berkemer SJ. Toward a Systematic Assessment of Sex Differences in Cystic Fibrosis. J Pers Med. 2023;13(6):924. https:\/\/doi.org\/10.3390\/jpm13060924.","journal-title":"J Pers Med"},{"issue":"1","key":"4362_CR55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcf.2023.05.009","volume":"23","author":"A Wang","year":"2024","unstructured":"Wang A, Lee M, Keller A, Jian S, Lowe K, Finklea JD, et al. Sex differences in outcomes of people with cystic fibrosis treated with elexacaftor\/tezacaftor\/ivacaftor. J Cyst Fibros. 2024;23(1):91\u20138. https:\/\/doi.org\/10.1016\/j.jcf.2023.05.009.","journal-title":"J Cyst Fibros"},{"key":"4362_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2466-14-26","volume":"14","author":"H Hebestreit","year":"2014","unstructured":"Hebestreit H, Schmid K, Kieser S, Junge S, Ballmann M, Roth K, et al. Quality of life is associated with physical activity and fitness in cystic fibrosis. BMC Pulm Med. 2014;14:26. https:\/\/doi.org\/10.1186\/1471-2466-14-26.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"4362_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03009734.2016.1225871","volume":"122","author":"J Hochw\u00e4lder","year":"2017","unstructured":"Hochw\u00e4lder J, Bergsten Brucefors A, Hjelte L. Psychometric evaluation of the Swedish translation of the revised Cystic Fibrosis Questionnaire in adults. Ups J Med Sci. 2017;122(1):61\u20136. https:\/\/doi.org\/10.1080\/03009734.2016.1225871.","journal-title":"Ups J Med Sci"},{"key":"4362_CR58","doi-asserted-by":"publisher","first-page":"100280","DOI":"10.1016\/j.jcte.2021.100280","volume":"26","author":"A Darukhanavala","year":"2021","unstructured":"Darukhanavala A, Merjaneh L, Mason K, Le T. Eating disorders and body image in cystic fibrosis. J Clin Transl Endocrinol. 2021;26:100280. https:\/\/doi.org\/10.1016\/j.jcte.2021.100280.","journal-title":"J Clin Transl Endocrinol"},{"issue":"1","key":"4362_CR59","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bodyim.2011.09.001","volume":"9","author":"S Tierney","year":"2012","unstructured":"Tierney S. Body image and cystic fibrosis: a critical review. Body Image. 2012;9(1):12\u20139. https:\/\/doi.org\/10.1016\/j.bodyim.2011.09.001.","journal-title":"Body Image"},{"issue":"4","key":"4362_CR60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jcf.2019.01.013","volume":"18","author":"KD Flewelling","year":"2019","unstructured":"Flewelling KD, Sellers DE, Sawicki GS, Robinson WM, Dill EJ. Social support is associated with fewer reported symptoms and decreased treatment burden in adults with cystic fibrosis. J Cyst Fibros. 2019;18(4):572\u20136. https:\/\/doi.org\/10.1016\/j.jcf.2019.01.013.","journal-title":"J Cyst Fibros"},{"key":"4362_CR61","doi-asserted-by":"publisher","first-page":"110607","DOI":"10.1016\/j.jpsychores.2021.110607","volume":"150","author":"A Gulledge","year":"2021","unstructured":"Gulledge A, Miller S, Mueller M. Social support and social isolation in adults with cystic fibrosis: An integrative review. J Psychosom Res. 2021;150:110607. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110607.","journal-title":"J Psychosom Res"},{"issue":"3","key":"4362_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1513\/AnnalsATS.201408-393OC","volume":"12","author":"AR Habib","year":"2015","unstructured":"Habib AR, Manji J, Wilcox PG, Javer AR, Buxton JA, Quon BS. A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):420\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.201408-393OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"4362_CR63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/occmed\/kqt140","volume":"64","author":"K Targett","year":"2014","unstructured":"Targett K, Bourke S, Nash E, Murphy E, Ayres J, Devereux G. Employment in adults with cystic fibrosis. Occup Med (Lond). 2014;64(2):87\u201394. https:\/\/doi.org\/10.1093\/occmed\/kqt140.","journal-title":"Occup Med (Lond)"},{"issue":"22","key":"4362_CR64","doi-asserted-by":"publisher","first-page":"11776","DOI":"10.3390\/ijerph182211776","volume":"18","author":"V Leso","year":"2021","unstructured":"Leso V, Carnovale V, Iacotucci P, Pacella D, Romano R, Della Volpe I, et al. Employment Status and Work Ability in Adults with Cystic Fibrosis. Int J Environ Res Public Health. 2021;18(22):11776. https:\/\/doi.org\/10.3390\/ijerph182211776.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"4362_CR65","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.chest.2021.11.001","volume":"161","author":"M Chin","year":"2022","unstructured":"Chin M, Brennan AL, Bell SC. Emerging Nonpulmonary Complications for Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series. Chest. 2022;161(5):1211\u201324. https:\/\/doi.org\/10.1016\/j.chest.2021.11.001.","journal-title":"Chest"},{"issue":"174","key":"4362_CR66","doi-asserted-by":"publisher","first-page":"240071","DOI":"10.1183\/16000617.0071-2024","volume":"33","author":"A Felipe Montiel","year":"2024","unstructured":"Felipe Montiel A, Fern\u00e1ndez A\u00c1, Amigo MC, Traversi L, Clofent Alarc\u00f3n D, Reyes KL, et al. The ageing of people living with cystic fibrosis: what to expect now? Eur Respir Rev. 2024;33(174):240071. PMID: 39477350; PMCID: PMC11522972.","journal-title":"Eur Respir Rev"},{"issue":"6","key":"4362_CR67","doi-asserted-by":"publisher","first-page":"e20230187","DOI":"10.36416\/1806-3756\/e20230187","volume":"49","author":"LVRFD Silva Filho","year":"2024","unstructured":"Silva Filho LVRFD, Athanazio RA, Tonon CR, Ferreira JC, Tanni SE. Use of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele: a systematic review and meta-analysis. J Bras Pneumol. 2024;49(6):e20230187. https:\/\/doi.org\/10.36416\/1806-3756\/e20230187.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"4362_CR68","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1038\/s41598-019-43652-2","volume":"9","author":"AR Habib","year":"2019","unstructured":"Habib AR, Kajbafzadeh M, Desai S, Yang CL, Skolnik K, Quon BS. A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis. Sci Rep. 2019;9(1):7234. https:\/\/doi.org\/10.1038\/s41598-019-43652-2.","journal-title":"Sci Rep"},{"issue":"16","key":"4362_CR69","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.3390\/ijms21165882","volume":"21","author":"A Gramegna","year":"2020","unstructured":"Gramegna A, Contarini M, Aliberti S, Casciaro R, Blasi F, Castellani C. From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis. Int J Mol Sci. 2020;21(16):5882. https:\/\/doi.org\/10.3390\/ijms21165882.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4362_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcf.2022.08.018","volume":"22","author":"I Fajac","year":"2023","unstructured":"Fajac I, Daines C, Durieu I, Goralski JL, Heijerman H, Knoop C, et al. Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor\/tezacaftor\/ivacaftor. J Cyst Fibros. 2023;22(1):119\u201323. https:\/\/doi.org\/10.1016\/j.jcf.2022.08.018.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"4362_CR71","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s41687-025-00879-0","volume":"9","author":"B Francesca","year":"2025","unstructured":"Francesca B, Gloria T, Antonella S, Ilaria M, Emily P, Sandra P, et al. Improved quality of life in cystic fibrosis patients observed up to 36 months after starting Elexacaftor\/Tezacaftor\/Ivacaftor treatment. J Patient Rep Outcomes. 2025;9(1):48. https:\/\/doi.org\/10.1186\/s41687-025-00879-0.","journal-title":"J Patient Rep Outcomes"},{"issue":"9","key":"4362_CR72","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.arbres.2023.05.017","volume":"59","author":"L Carrasco Hern\u00e1ndez","year":"2023","unstructured":"Carrasco Hern\u00e1ndez L, Gir\u00f3n Moreno RM, Balaguer Cartagena MN, Pel\u00e1ez A, Sole A, \u00c1lvarez Fern\u00e1ndez A, et al. Experience With Elexacaftor\/Tezacaftor\/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease. Arch Bronconeumol. 2023;59(9):556\u201365. https:\/\/doi.org\/10.1016\/j.arbres.2023.05.017.","journal-title":"Arch Bronconeumol"},{"key":"4362_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12955-015-0293-6","volume":"13","author":"A Quittner","year":"2015","unstructured":"Quittner A, Suthoff E, Rendas-Baum R, Bayliss MS, Sermet-Gaudelus I, Castiglione B, et al. Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial. Health Qual Life Outcomes. 2015;13:93. https:\/\/doi.org\/10.1186\/s12955-015-0293-6.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"4362_CR74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jpainsymman.2016.03.023","volume":"52","author":"N Lechtzin","year":"2016","unstructured":"Lechtzin N, Allgood S, Hong G, Riekert K, Haythornthwaite JA, Mogayzel P, et al. The Association Between Pain and Clinical Outcomes in Adolescents With Cystic Fibrosis. J Pain Symptom Manage. 2016;52(5):681\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.03.023.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"4362_CR75","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jcf.2025.01.009","volume":"24","author":"A Ward","year":"2025","unstructured":"Ward A, Mauleon R, Davidson G, Ooi CY, Rosi\u0107 N. Pain in adults with cystic fibrosis - Are we painfully unaware? J Cyst Fibros. 2025;24(2):236\u201345. https:\/\/doi.org\/10.1016\/j.jcf.2025.01.009.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"4362_CR76","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pmn.2017.11.011","volume":"19","author":"SJ Allgood","year":"2018","unstructured":"Allgood SJ, Kozachik S, Alexander KA, Thaxton A, Vera M, Lechtzin N. Descriptions of the Pain Experience in Adults and Adolescents with Cystic Fibrosis. Pain Manag Nurs. 2018;19(4):340\u20137. https:\/\/doi.org\/10.1016\/j.pmn.2017.11.011.","journal-title":"Pain Manag Nurs"},{"key":"4362_CR77","doi-asserted-by":"publisher","first-page":"101279","DOI":"10.1016\/j.smrv.2020.101279","volume":"51","author":"J Reiter","year":"2020","unstructured":"Reiter J, Gileles-Hillel A, Cohen-Cymberknoh M, Rosen D, Kerem E, Gozal D, et al. Sleep disorders in cystic fibrosis: A systematic review and meta-analysis. Sleep Med Rev. 2020;51:101279. https:\/\/doi.org\/10.1016\/j.smrv.2020.101279.","journal-title":"Sleep Med Rev"},{"issue":"2","key":"4362_CR78","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1479972316631135","volume":"13","author":"AL Lee","year":"2016","unstructured":"Lee AL, Rawlings S, Bennett KA, Armstrong D. Pain and its clinical associations in individuals with cystic fibrosis: A systematic review. Chron Respir Dis. 2016;13(2):102\u201317. https:\/\/doi.org\/10.1177\/1479972316631135.","journal-title":"Chron Respir Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04362-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04362-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:56:29Z","timestamp":1781736989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04362-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4362"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04362-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before participating in the study, all invited individuals were presented with a detailed description that outlined its purpose, subject matter, the types of questionnaires used, and the estimated time required for completion. Participation was entirely voluntary, and there would be no repercussions for anyone choosing not to participate. Consent to participate was granted electronically by selecting the appropriate option on the survey form. Respondents were assured that their answers would remain anonymous and that the collected data would be used solely for scientific analysis. Each participant was informed that completing the questionnaire constituted consent for the anonymised results to be used in scientific publications. The entire research project was designed and conducted in line with established ethical principles governing scientific research, including the guidelines outlined in the Helsinki Declaration. Before commencing the study, its framework was submitted for review to the Bioethics Committee at the Medical University of Warsaw. The Committee confirmed that the research procedures adhered to the ethical standards required for studies involving human subjects (statement no. AKBE\/281\/2023 dated 9 October 2023). Additionally, the project received approval and organisational support from the Postgraduate Medical Education Centre in Warsaw.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this manuscript, the authors used ChatGPT-5 to improve language clarity and grammar. All content was critically reviewed and verified by the authors to ensure accuracy and integrity. The authors reviewed and edited the output and take full responsibility for the content of this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI use"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}